Sponsor

Universidad Europea de Madrid

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Universidad Europea de Madrid appears in 19 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials19
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

19 shown
Continuous Subcutaneous Glucose Monitoring in Critical PatientsNCT06234787 · lead sponsor · 2023-11-30
RECRUITING
Effects of a Physical Exercise Intervention During Neoadjuvant Chemotherapy in Women With Breast CancerNCT04135586 · lead sponsor · 2020-01-01
RECRUITING
EFFECTIVENESS OF COMBINED CONCENTRIC AND ECCENTRIC AEROBIC EXERCISE ON A TREADMILL IN PATIENTS WITH COPD: A RANDOMIZED CLINICAL TRIAL.NCT07627035 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Metabolic Flexibility in Patients With Early Triple-negative Breast CancerNCT07484776 · lead sponsor · 2026-02-10
ACTIVE_NOT_RECRUITING
Effect of a Specific Hand Intervention in Women With Arthralgia Secondary to Hormone Therapy Following Breast Cancer.NCT06746376 · lead sponsor · 2025-04-01
NOT_YET_RECRUITING
Respiratory Muscle Training Program in Patients With Multiple SclerosisNCT06405451 · lead sponsor · 2024-04-09
COMPLETED
Efectivity of Non-invasive Neuromodulation in Parasympathic Nervous System and Vascular SystemNCT06320171 · lead sponsor · 2024-04-01
COMPLETED
Effectiveness of the EXOPULSE Mollii Ⓡ Suit in Patients With Multiple SclerosisNCT06384729 · lead sponsor · 2024-04-01
COMPLETED
Evaluation of the Influence of a Core Muscle Control-Based Rehabilitation Program Patients With Multiple SclerosisNCT06384716 · lead sponsor · 2024-02-19
UNKNOWN
Aerobic Exercise and Resistant HypertensionNCT05563077 · lead sponsor · 2022-10-05
ACTIVE_NOT_RECRUITING
Gait Re-education Program in Subjects With Parkinson´s DiseaseNCT05131880 · lead sponsor · 2021-11-01
COMPLETED
Synergic Effects of Physical Activity and Probiotic on Gut Immune System and Quality of Life of Breast Cancer Survivors.NCT03760653 · lead sponsor · 2018-10-01
WITHDRAWN
Acute Effect of Chromatic Environment During ChemotherapyNCT03873519 · lead sponsor · 2018-04-15
UNKNOWN
Effects of an Exercise Program for Children With AsthmaNCT02693301 · lead sponsor · 2016-01-01
COMPLETED
Whole Muscle Exercise Training (WHOLEi+12) in Pulmonary HypertensionNCT02288442 · lead sponsor · 2015-01-01
COMPLETED
Design of Personalised SupplemenTs Based on the Gut MicRobiota Through Artificial Intelligence for Alzheimer's PatientsNCT06199193 · collaborator · 2024-02-01
UNKNOWN
Physical Exercise for Breast Cancer Survivors: Face-to-face Versus Home-basedNCT05071560 · collaborator · 2021-05-01
COMPLETED
Study Comparing Two Strategies of Exercise in Breast and Colon Cancer Survivors and Their Impact on FatigueNCT02647398 · collaborator · 2016-01-01
COMPLETED
Physical Activity in Bariatric PatientsNCT03666481 · collaborator · 2011-11-16
COMPLETED

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Universidad Europea de Madrid as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor15
collaborator4
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.